Thrombotic thrombocytopenic purpura cases after CoronaVac raise concerns over vaccine safety

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

Aurora Q3 Cannabis Sales Slip 3% to C$53.3 Million

Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results Achieves Second Sequential Quarter of Positive Adjusted EBITDA1 Net Revenue Reaches $64 Million,

June 14, 2023

ALTO-300 by Alto Neuroscience for Major Depressive Disorder: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

November 5, 2023

AI tool for heart failure screening demonstrates long-term cost savings

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than

December 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.